Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.66 USD | +1.48% | +7.96% | +6.48% |
Mar. 13 | Top Premarket Decliners | MT |
Mar. 12 | JPMorgan Adjusts Price Target on iTeos Therapeutics to $27 From $29, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.48% | 419M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- Wedbush Removes Outperform-Rated ITeos Therapeutics From Best Ideas List; Price Target is $49